Pascal joined the RiverVest team as Senior Associate in 2021. In this role, she focuses on sourcing and completing due diligence on prospective portfolio companies in both the therapeutics and medical devices sectors. She serves as an observer at Bluejay Therapeutics, Avalyn Pharmaceuticals, and Biolinq.  She also supports the operational activities of RiverVest’s portfolio companies.

Prior to joining the team, Pascal spent nearly 4 years as an Investment Associate at Kairos Ventures, where she focused on investments in the life sciences. While at Kairos, she sourced new opportunities for investment, led due diligence, and served on the Board of Directors of several portfolio companies.

Like many on the RiverVest team, Pascal is a scientist by training.  She earned a Ph.D. in Molecular Biology at UCLA, where she studied the atomic structures of proteins associated with Alzheimer’s disease and type-II diabetes and worked to create compounds that inhibited these structures. Prior to graduate school, Pascal worked as Junior Specialist at the Development Biology Center at UC Irvine.  She earned a B.S. in Developmental and Cell Biology with a Minor in Business Management from UC Irvine.